Author:
Spagnul S J T,Cabral P H O,Verndl D O,Glina S
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Hofner K, Claes H, De Reijke TM, Folkestad B, Speakman MJ . Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur Urol 1999; 36: 335–341.
2. Marberger M, Harkaway R, de la Rosette J . Optimising the medical management of benign prostatic hyperplasia. Eur Urol 2004; 45: 411–419.
3. Gilling P, Jacobi G, Tammela T . Efficacy of dutasteride and finasteride for the treatment of benign prostatic hyperplasia: results of the 1-year Enlarged Prostate International Comparative Study (EPICS). Br J Urol 2005; 95: 1–104.
4. McConnell JD, Roehrborn CG, Bautista OM, Andriole Jr GL, Dixon CM, Kusek JW et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003; 349: 2387–2398.
5. Roehrborn CG, Siami P, Barkin J, Damiao R, Major-Walker K, Morrill B et al. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J Urol 2008; 179: 616–621; discussion 621.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献